Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibromyalgia ketamine study
NL-OMON22499Not yet recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of esketamine in fibromyalgia (FM) (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Pain on visual analogue scale and Ketamine plasma concentration. Planned start Feb 2010; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NL-OMON22499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22499.